Acinus: A Novel Corepressor of RAR-Regulated Gene Expression

Acinus:RAR 调节基因表达的新型辅阻遏物

基本信息

  • 批准号:
    7988306
  • 负责人:
  • 金额:
    $ 4.4万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-07-05 至 2011-11-20
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Retinoic acid (RA), the most potent natural form of vitamin A, plays an important role in mediating the growth and differentiation of both normal and transformed cells. RA functions by transcriptionally regulating gene expression via retinoic acid receptors (RARs) and retinoid X receptors (RXRs). Three distinct but highly homologous RAR subtypes have been described termed RARalpha, RARbeta and RARgamma. RARs contain a highly conserved DNA binding domain (domain C), a well conserved ligand binding domain (domain E), and three or four additional domains that are not as well conserved (domains A, B, D and F). There is a limited amount of information concerning the function of the A/B domains of RARs however it is known to contain ligand-independent transactivation activity (AF-1) that synergizes with the ligand- dependent transactivation activity (AF-2) located in the E domain. Preliminary data presented in this application demonstrate the identification of Acinus as a new protein that binds specifically to the B-domain of RARs and represses transcription in a ligand-independent fashion. Recently reports suggest that Acinus may also function as a splicing factor. We hypothesize that Acinus functions as a novel corepressor protein that plans an important role in the cotranscriptional regulation of both RAR-regulated transcription and the splicing of RAR-regulated pre-mRNAS. Specifically we will address the following 4 aims: (1) Complete the characterization of Acinus as a RAR binding protein that represses RAR-dependent transcription; (2) Examine the role of Acinus in mediating both RAR-regulated gene expression and RA-dependent differentiation of P19 cells; (3) Examine the role of phosphorylation of specific serine residues of Acinus in mediating its cellular localization and repression of gene expression; and (4) Begin to elucidate the mechanism by which Acinus alters RAR-regulated gene expression.
描述(由申请人提供):维甲酸(RA)是维生素A的最有效的天然形式,在介导正常和转化细胞的生长和分化中起重要作用。RA通过视黄酸受体(RAR)和类维生素A X受体(RXR)转录调节基因表达发挥功能。已经描述了三种不同但高度同源的RAR亚型,称为RAR α、RAR β和RAR γ。RAR含有高度保守的DNA结合结构域(结构域C)、充分保守的配体结合结构域(结构域E)和三个或四个不那么保守的另外的结构域(结构域A、B、D和F)。关于RAR的A/B结构域的功能的信息有限,然而已知其含有与位于E结构域中的配体依赖性反式激活活性(AF-2)协同的配体非依赖性反式激活活性(AF-1)。本申请中提供的初步数据证明了Acinus作为一种新蛋白的鉴定,该蛋白特异性结合RAR的B结构域并以配体非依赖性方式抑制转录。最近的研究表明腺泡也可能作为剪接因子发挥作用。我们假设腺泡作为一种新的辅阻遏蛋白发挥作用,该蛋白在RAR调节的转录和RAR调节的前mRNAS的剪接的共转录调节中起重要作用。具体而言,我们将致力于以下4个目标:(1)完成Acinus作为RAR结合蛋白的表征,其抑制RAR依赖性转录;(2)检测Acinus在介导RAR调节的基因表达和RA依赖性P19细胞分化中的作用;(3)研究腺泡特异性丝氨酸残基的磷酸化在介导其细胞定位和抑制基因表达中的作用;(4)开始阐明腺泡改变RAR调节基因表达的机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DIANNE R SOPRANO其他文献

DIANNE R SOPRANO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DIANNE R SOPRANO', 18)}}的其他基金

PBX AND Retinoic Acid-dependent Differentiation
PBX 和视黄酸依赖性分化
  • 批准号:
    8006977
  • 财政年份:
    2010
  • 资助金额:
    $ 4.4万
  • 项目类别:
Acinus: A Novel Corepressor of RAR-Regulated Gene Expression
Acinus:RAR 调节基因表达的新型辅阻遏物
  • 批准号:
    7886506
  • 财政年份:
    2007
  • 资助金额:
    $ 4.4万
  • 项目类别:
Acinus: A Novel Corepressor of RAR-Regulated Gene Expression
Acinus:RAR 调节基因表达的新型辅阻遏物
  • 批准号:
    7460659
  • 财政年份:
    2007
  • 资助金额:
    $ 4.4万
  • 项目类别:
Acinus: A Novel Corepressor of RAR-Regulated Gene Expression
Acinus:RAR 调节基因表达的新型辅阻遏物
  • 批准号:
    8098825
  • 财政年份:
    2007
  • 资助金额:
    $ 4.4万
  • 项目类别:
Acinus: A Novel Corepressor of RAR-Regulated Gene Expression
Acinus:RAR 调节基因表达的新型辅阻遏物
  • 批准号:
    7856324
  • 财政年份:
    2007
  • 资助金额:
    $ 4.4万
  • 项目类别:
Acinus: A Novel Corepressor of RAR-Regulated Gene Expression
Acinus:RAR 调节基因表达的新型辅阻遏物
  • 批准号:
    7642538
  • 财政年份:
    2007
  • 资助金额:
    $ 4.4万
  • 项目类别:
Acinus: A Novel Corepressor of RAR-Regulated Gene Expression
Acinus:RAR 调节基因表达的新型辅阻遏物
  • 批准号:
    7315168
  • 财政年份:
    2007
  • 资助金额:
    $ 4.4万
  • 项目类别:
13th Biennial FASEB Summer Conference on Retinoids
第 13 届 FASEB 类维生素A双年度夏季会议
  • 批准号:
    7114510
  • 财政年份:
    2006
  • 资助金额:
    $ 4.4万
  • 项目类别:
PBX AND Retinoic Acid-dependent Differentiation
PBX 和视黄酸依赖性分化
  • 批准号:
    7328592
  • 财政年份:
    2005
  • 资助金额:
    $ 4.4万
  • 项目类别:
PBX AND Retinoic Acid-dependent Differentiation
PBX 和视黄酸依赖性分化
  • 批准号:
    7163061
  • 财政年份:
    2005
  • 资助金额:
    $ 4.4万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 4.4万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 4.4万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.4万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.4万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 4.4万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.4万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 4.4万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 4.4万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 4.4万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.4万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了